CAS: 544478-19-5 - methyl 4-(3-dioxaziridin-3-ylphenyl)-5-(3-hydroxypropanoyl)-2,6-dimethyl-1-prop-2-yn-1-yl-1,4-dihydropyridine-3-carboxylate
Formula:C21H22N2O6
InChI:InChI=1/C21H22N2O6/c1-5-10-22-13(2)18(17(25)9-11-24)20(19(14(22)3)21(26)27-4)15-7-6-8-16(12-15)23-28-29-23/h1,6-8,12,20,24H,9-11H2,2-4H3
- Synonyms:
- 3-Pyridinecarboxylic acid, 4-[3-(3-dioxaziridinyl)phenyl]-1,4-dihydro-5-(3-hydroxy-1-oxopropyl)-2,6-dimethyl-1-(2-propyn-1-yl)-, methyl ester
- Methyl 4-[3-(dioxaziridin-3-yl)phenyl]-5-(3-hydroxypropanoyl)-2,6-dimethyl-1-(prop-2-yn-1-yl)-1,4-dihydropyridine-3-carboxylate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
MRS1845 REF: TM-T12108CAS: 544478-19-5 | - - - | 53.00 €~223.00 € | Wed 08 May 24 | |
MRS 1845 REF: 7W-GL8013CAS: 544478-19-5 | - - - | To inquire | Mon 13 May 24 | |
MRS 1845 REF: 3D-UWA47819CAS: 544478-19-5 | Min. 95% | 246.00 €~1,413.00 € | Tue 21 May 24 |
MRS1845
CAS:544478-19-5
MRS1845 is a selective inhibitor of store-operated calcium (SOC) channel (IC50 of 1.7 μM).
Formula:
C21H22N2O6
Molecular weight:
398.41
Ref: TM-T12108
2mg | 73.00 € | |
5mg | 119.00 € | |
10mg | 223.00 € | |
1ml*10 (DMSO) | 129.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
MRS 1845
CAS:544478-19-5
MRS 1845 is a cytostatic drug that inhibits the growth of cancer cells by inhibiting …
Formula:
C21H22N2O6
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
398.41 g/mol
Ref: 3D-UWA47819
5mg | 246.00 € | |
10mg | 369.00 € | |
25mg | 616.00 € | |
50mg | 939.00 € | |
100mg | 1,413.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024